Professional Documents
Culture Documents
ICH Official Web Site - ICH
ICH Official Web Site - ICH
Quality Guidelines
Harmonisation achievements in the Quality area include pivotal milestones such as the conduct of stability studies, defining relevant
thresholds for impurities testing and a more flexible approach to pharmaceutical quality based on Good Manufacturing Practice (GMP)
risk management.
Q1A - Q1F
Stability
Q1B Stability Testing : Photostability Testing of New Drug Substances and Products
Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and
Q1D
Products
Q1F Stability Data Package for Registration Applications in Climatic Zones III and IV
Q2 Analytical
Validation
Q2(R2)/Q14 EWG Analytical Procedure Development and Revision of Q2 (R1) Analytical Validation
Q3A - Q3E
Impurities
https://www.ich.org/page/quality-guidelines 1/4
11/22/23, 12:36 PM ICH Official web site : ICH
Q4A - Q4B
Pharmacopoeias
Regions
Q4B Annex 2(R1) Test for Extractable Volume of Parenteral Preparations General Chapter
Q4B Annex 3(R1) Test for Particulate Contamination: Sub-Visible Particles General Chapter
Q4B Annex Microbiological Examination of Non-Sterile Products: Tests for Specified Micro-
Q4B Annex 13 Bulk Density and Tapped Density of Powders General Chapter
or Animal Origin
Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human
Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived
Q5B
Protein Products
Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological
Q5C
Products
Derivation and Characterisation of Cell Substrates Used for Production of
Q5D
Biotechnological/Biological Products
Comparability of Biotechnological/Biological Products Subject to Changes in their
Q5E
Manufacturing Process
https://www.ich.org/page/quality-guidelines 2/4
11/22/23, 12:36 PM ICH Official web site : ICH
Q6A- Q6B
Specifications
Specifications : Test Procedures and Acceptance Criteria for New Drug Substances
Q6A
and New Drug Products: Chemical Substances
Specifications : Test Procedures and Acceptance Criteria for
Q6B
Biotechnological/Biological Products
Q7 Good Manufacturing
Practice
Pharmaceutical Ingredients
Q8 Pharmaceutical
Development
Q9 Quality Risk
Management
Biotechnological/Biological Entities)
Questions & Answers: Selection and Justification of Starting Materials for the
Q11 Q&As
Q12 Lifecycle
Management
Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle
Q12
Management
Training on Regulatory and Technical Considerations for Pharmaceutical Product
Q12 IWG
Lifecycle Management
https://www.ich.org/page/quality-guidelines 3/4
11/22/23, 12:36 PM ICH Official web site : ICH
Q13 Continuous Manufacturing of Drug Substances and Drug Products
Q13 IWG Training on Continuous Manufacturing of Drug Substances and Drug Products
Q2(R2)/Q14 EWG Analytical Procedure Development and Revision of Q2 (R1) Analytical Validation
https://www.ich.org/page/quality-guidelines 4/4